by Arlene Chan, Astrid
Bauwens, Sally Pontre, Sally Jackson, Frances McGlone, Tracie Ernenwein, Jun
Chih, Christopher Reid
Hair loss as a result of
chemotherapy for early breast cancer (EBC) is a frequent and distressing side
effect. Minimising hair loss may improve mood and body image. Our aim was to
determine scalp cooling (SC) efficacy in EBC patients receiving contemporary
chemotherapy regimen, to inform future patients choice to use SC or not.
